ITIH5 抗体 (AA 35-161) (HRP)
Quick Overview for ITIH5 抗体 (AA 35-161) (HRP) (ABIN7156528)
抗原
See all ITIH5 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 35-161
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human Inter-alpha-trypsin inhibitor heavy chain H5 protein (35-161AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Optimal working dilution should be determined by the investigator.
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - ITIH5 (Inter alpha Globulin Inhibitor H5 (ITIH5))
- 
                                            别名
- ITIH5
- 
                                            背景
- 
                        Background: May act as a tumor suppressor. Aliases: ITIH5 antibody, KIAA1953 antibody, PP14776 antibody, UNQ311/PRO354 antibody, Inter-alpha-trypsin inhibitor heavy chain H5 antibody, ITI heavy chain H5 antibody, ITI-HC5 antibody, Inter-alpha-inhibitor heavy chain 5 antibody 
- 
                                            UniProt
- Q86UX2
- 
                                            途径
- Glycosaminoglycan Metabolic Process
 抗原
- 
                    
 
                                     
                                     
                                    